{'fraction_non_alphanumeric': 0.019430051813471502, 'fraction_numerical': 0.0, 'mean_word_length': 6.653465346534653, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Comparative gastric motility study of EnterraTM Therapy and neural gastric electrical stimulation in an acute canine model

Background  Gastric electrical stimulation (GES) is an avenue for treating gastroparesis and obesity by controlling gastric motility using electrically mediated gastric contractions. Neural gastrointestinal electrical stimulation (NGES) is a GES modality capable of producing strong lumen‐occluding local gastric contractions. Conversely, EnterraTM Therapy, a commercial implantable gastric electrical stimulator, has been utilized to treat symptoms of gastroparesis, but its nominal electrical parameters are not capable of generating lumen‐occluding contractions. However, comparative studies between these two stimulation modalities are lacking.